Conjugated linoleic acid and weight loss;Ácido linoléico conjugado e perda de peso

Revista de Nutricao

Volumn 18, Issue 3, 2005, Pages 391-399

  Mourão, Denise Machado ^a   Monteiro, Josefina Bressan Resende ^a   Costa, Neuza Maria Brunoro ^a   Stringheta, Paulo César ^a   Minim, Valéria Paula Rodrigues ^a   Dias, Cristina Maria Ganns Chaves ^a  

^a FEDERAL UNIVERSITY OF VIÇOSA   (Brazil)

Author keywords

Body composition; Linoleic acid; Obesity; Weight loss

Indexed keywords

ANTIOBESITY AGENT; LINOLEIC ACID;

ADIPOSE TISSUE; BODY COMPOSITION; DRUG CONJUGATION; DRUG INDUSTRY; ENERGY EXPENDITURE; FOOD INDUSTRY; HEALTH PRACTITIONER; HUMAN; LIPOGENESIS; LIPOLYSIS; OBESITY; REVIEW; WEIGHT REDUCTION;

MAMMALIA;

EID: 24744461193     PISSN: 14155273     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1415-52732005000300011     Document Type: Review

References (36)

1. Bell S, Goodrick G. A functional food product for the management of weight. Crit Rev Food Sci Nutr. 2002; 42(2):163-78.
2. Institute of Medicine. National Academy of Science. Opportunities in the Nutrition and Food Sciences. Washington DC: Institute of Medicine; 1994.
3. Agência Nacional de Vigilância Sanitária. Diretrizes básicas para análise e comprovação de propriedades funcionais. In: Regulamento técnico. Brasília: Agência Nacional de Vigilância Sanitária; 1999. Resolução n. 18.
4. World Health Organization. Obesity: preventing and managing the global epidemic. Geneva: World Health Organization; 1998.
5. Federal Trade Comission. [homepage on the internet]. Weight-loss advertising. An analysis of current trends: a federal trade commission staff report [updated, 2002 Sep 17]. Available from: URL: http://www.ftc.gov
6. Pariza MW, Park Y, Cook ME. The biologically active isomers of conjugated linoleic acid. Prog Lipid Res. 2001; 40(4):283-98.
7. Park Y, Albright KJ, Liu W, Storkson JM, Cook ME, Pariza MW. Effect of conjugated linoleic acid on body composition in mice. Lipids. 1997; 32(8): 853-8.
8. West DB, Blohm FY, Truett AA, DeLany JP. Conjugated linoleic acid persistently increases total energy expenditure in AKR/J mice without increasing uncoupling protein gene expression. J Nutr. 2000; 130(10):2471-7.
9. DeLany JP, Blohm F, Truett AA, Scimeca JA, West DB. Conjugated linoleic acid rapidly reduces body fat content in mice without affecting energy intake. Am J Physiol. 1999; 276(4 Pt 2):R1172-9.
10. Park Y, Albright KJ, Storkson JM, Liu W, Cook ME, Pariza MW. Changes in body composition in mice during feeding and withdrawal of conjugated linoleic acid. Lipids. 1999; 34(3):243-8.
11. Tsuboyama-Kasaoka N, Takahashi M, Tanemura K, Kim HJ, Tange T, Okuyama H, et al. Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes. 2000; 49(9):1534-42.
12. West DB, Delany JP, Camet PM, Blohm F, Truett AA, Scimeca J. Effects of conjugated linoleic acid on body fat and energy metabolism in the mouse. Am J Physiol. 1998; 275(3 Pt 2):R667-72.
13. Azain MJ, Hausman DB, Sisk MB, Flatt WP, Jewell DE. Dietary conjugated linoleic acid reduces rat adipose tissue cell size rather than cell number. J Nutr. 2000; 130(6):1548-54.
14. Kelly GS. Conjugated linoleic acid: A review. Altern Med Rev. 2001; 6(4):367-82.
15. Park Y, Storkson JM, Albright KJ, Liu W, Pariza MW. Evidence that the trans-10,cis-12 isomer of conjugated linoleic acid induces body composition changes in mice. Lipids. 1999; 34(3):235-41.
16. Atkinson R. Conjugated linoleic acid for altering body composition and treating obesity. In: Yuraweez M, Mossoba M, Kramer J, Pariza M, Nelson G, editors. Advances in conjugated linoleic acid research. Champaign, IL: AOCS Press; 1999. P.353-438.
17. Zambell KL, Keim NL, Van Loan MD, Gale B, Benito P, Kelley DS, et al. Conjugated linoleic acid supplementation in humans: Effects on body composition and energy expenditure. Lipids. 2000; 35(7):777-82.
18. Blankson H, Stakkestad JA, Fagertun H, Thom E, Wadstein J, Gudmundsen O. Conjugated linoleic acid reduces body fat mass in overweight and obese humans. J Nutr. 2000; 130(12):2943-8.
19. Riserus U, Berglund L, Vessby B. Conjugated linoleic acid (CLA) reduced abdominal adipose tissue in obese middle-aged men with signs of the metabolic syndrome: a randomised controlled trial. Int J Obes. 2001; 25(8):1129-35.
20. Kamphuis MM, Lejeune MP, Saris WH, Westerterp-Plantenga MS. The effect of conjugated linoleic acid supplementation after weight loss on body weight regain, body composition, and resting metabolic rate in overweight subjects. Int J Obes. 2003; 27(7):840-7.
21. Park Y, Pariza MW. Lipoxygenase inhibitors inhibit heparin-releasable lipoprotein lipase activity in 3T3-L1 adipocytes and enhance body fat reduction in mice by conjugated linoleic acid. Biochim Biophys Acta. 2001; 1534(1):27-33.
22. Bjorntrop P. Visceral obesity: a "civilization syndrome". Obes Res. 1993; 1(3):206-22.
23. Ip M, Masso-Welch P, Shoemaker S, Shea-Eaton W. Conjugated linoleic acid inhibits proliferation and induces apoptosis of normal rat mammary epithelial cells in primary culture. Exp Cell Res. 1999; 250(1):22-34.
24. Brodie A, Manning V, Ferguson K, Jewell D, Hu C. Conjugated linoleic acid inhibits differentiation of pre-and post-confluent 3T3-L1 preadipocytes but inhibits cell proliferation only in preconfluent cells. J Nutr. 1999; 129(3):602-6.
25. Satory D, Smith S. Conjugated linoleic acid inhibits proliferation but stimulates lipid filling of murine 3T3-L1 preadipocytes. J Nutr. 1999; 129(1):92-7.
26. Miner JL, Cederberg CA, Nielsen MK, Chen X, Baile CA. Conjugated Linoleic Acid (CLA), Body Fat, and Apoptosis. Obes Res. 2001; 9(2):129-34.
27. Portocarrero C, Bauman D, Barbano D, Zierath J, Houseknecht K. Regulation of UCP1 and UCP2 gene expression by dietary conjugated linoleic acid (CLA) in zucker diabetic fatty (ZDF) rats. In: American Diabetes Association (ADA) annual meeting; 1999 June 17-24; San Diego; 1999. (Abstract - 0021).
28. Ryder JW, Portocarrero CP, Song XM, Cui L, Yu M, Combatsiaris T, et al. Isomer-Specific Antidiabetic Properties of Conjugated Linoleic Acid: Improved Glucose Tolerance, Skeletal Muscle Insulin Action, and UCP-2 Gene Expression. Diabetes. 2001; 50(5):1149-57.
29. Rothwell N. Thermogenesis: where are we and where are we going? Report of a workshop held in London 21st April 2001, convened by Professor Mike Stock. Int J Obes. 2001; 25(9):1272-4.
30. Kawada T. Lipid metabolism related nuclear receptor: the structure, function, expression and classification of peroxisome proliferation-activated receptor (PPAR). Nippon Rinsho. 1998; 56(7): 1722-8.
31. Moya-Camarena SY, Vanden Heuvel JP, Blanchard SG, Leesnitzer LA, Belury MA. Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPAR alpha. J Lipid Res. 1999; 40(8): 1426-33.
32. Adams M, Montague CT, Prins JB, Holder JC, Smith As, Sanders L, et al. Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation. J Clin Invest. 1997; 100(12): 3149-53.
33. Camirand A, Marie V, Rabelo R, Silva J. Thiazolidinediones stimulate uncoupling protein-2 expression in cell lines representing white and brown adipose tissues and skeletal muscle. Endocrinology. 1998; 139(1):428-31.
34. Riserus U, Smedman A, Basu S, Vessby B. Conjugated Linoleic Acid (CLA) and Body Weight Regulation in Humans. Lipids. 2003; 38(2): 133-37.
35. Smedman A, Vessby B. Conjugated linoleic acid supplementation in humans-metabolic effects. Lipids. 2001; 36(8):773-81.
36. Choi Y, Park Y, Pariza M, Ntambi J. Regulation of stearoyl-CoA desaturase activity by the trans-10,ds-12 isomer of conjugated linoleic acid in HepG2 cells. Biochem Biophys Res Commun. 2001; 284(3):689-93.